Ross Perot Commits $20 Million to UT MD Anderson Cancer Center
Gift to Advance Personalized Cancer Therapy as the 'Gold Standard' in Oncology Care
MD Anderson News Release 08/18/10
Dallas businessman and philanthropist H. Ross Perot has donated $20 million to The University of Texas MD Anderson Cancer Center for research to advance and design novel targeted therapies.
The funds will be divided equally between two new initiatives at MD Anderson: an Institute for Personalized Cancer...
Media Visitation Terms and Conditions
TERMS AND CONDITIONS APPLICABLE TO ACCESS AND USE OF
UT MD ANDERSON’S FACILITIES BY NEWS MEDIA ORGANIZATIONS
Access to and use of...
Novel Role: EZH2 Boosts Creation of Ovarian Cancer Blood Vessels
Scientists use siRNA-loaded nanoparticles to stifle protein associated with poor survival
MD Anderson News Release 08/16/10
Researchers Identify Potential New Target for Ovarian Cancer
Inhibiting a cell division-regulating protein can improve response to taxane chemotherapy
MD Anderson News Release 08/16/10
For the first time, Salt Inducible Kinase 2 (SIK2) has been found to play a critical role in cell division and to regulate the response of some ovarian cancers to chemotherapy.
Findings were reported by researchers from The University of Texas MD Anderson Cancer Center in the August issue of...
SUMO Works with Replication Protein A Complex to Repair DNA
Molecular connection is crucial to fix DNA double-strand breaks
MD Anderson News Release 08/12/10
A team of investigators led...